Mazdutide vs. Tirzepatide: Is This New Drug the Ultimate “Mounjaro Killer”?
The landscape of metabolic pharmacotherapy is moving at a staggering pace. A few years ago, the introduction of selective glucagon-like peptide-1 (GLP-1) receptor agonists fundamentally changed how the medical community approaches chronic weight management. Shortly after, tirzepatide arrived and shifted the paradigm further by targeting two metabolic pathways simultaneously, achieving weight reduction numbers previously seen […]